Mood Disorder

APA’s 2017 Consensus on Ketamine: A Paradigm Shift in Treating Mood Disorders

web-admin / November 22, 2024

Introduction:The 2017 consensus statement by the APA Council of Research Task Force on Novel Biomarkers and Treatments, led by Sanacora […]

Depression, Ketamine Therapy, Mood Disorder, Research

Ketamine Therapy for PTSD and Treatment-Resistant Depression: Discover the Benefits & Process

web-admin / March 21, 2024

“Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression“ by Carlos A. Zarate Jr., Jaskaran B. Singh,

VitalPoint Technologies, Inc.

Disclaimer

None of the statements in this announcement or via any web sites linked herein have been evaluated by the FDA. Furthermore, none of the statements in this announcement or any web sites linked herein should be construed as dispensing medical advice or making claims regarding the cure of diseases. You should consult a licensed health care professional before starting any supplement, dietary, or exercise program, especially if you are pregnant or have any pre-existing injuries or medical conditions. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any diseases.